Delivery Order SPE2DB22D3004-SPE2DB25FRN55
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,738.89 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/mL syringes. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among eligible vendors. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide ENBREL 50 MG/ML SYRINGEML with a potential value of $8,609.42. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $8,149.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML, a specialty medication, with a completion date of September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,152.14 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENBREL 50 MG/ML syringes. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA Troop Support Medical, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,631.90 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML syringes. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The $9,158.68 contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 23, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML syringes. The award, valued at $8,591.28, is a firm-fixed-price contract with a completion date of December 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,280.31 firm fixed price delivery order is for the supply of Enbrel 25 mg/0.5 ml syringes. This contract is not set aside and represents a task order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a $51,462.68 firm fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of ENBREL 50 MG/ML SURECLICK syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has a completion date...
- This is a $17,677.23 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ENBREL 50 MG/ML syringes, with a performance period through May 23, 2022. Amerisourcebergen Drug Corp is the prime contractor and has also been awarded a $999,999,999.00 indefinite delivery contract by DLA to provide a comprehensive range of...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRN55Delivery Order
The Defense Logistics Agency awarded a $9,158.68 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Enbrel 50 mg/ml syringes. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a near-term pharmaceutical supply requirement within the military healthcare supply chain. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare systems, enabling the company to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal procurement requirements through competitive awards and serves critical medical supply needs for the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 7/18/25 |